TARGET
saveIL-23
Interleukin-23; psoriasis and IBD target.
also known as: il23, interleukin-23
drugs
0
catalysts
0
news
15
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPOfiercebiotech · 1mo ago
- Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trialsfiercebiotech · 1mo ago
- InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis testfiercebiotech · 1mo ago
- Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 updatefiercebiotech · 1mo ago
- Braveheart, Attovia join next wave of biotech IPOsbiopharma dive · 1mo ago
comments(0)
5-min edit window · permanent after that